IntegraMed Investor Says $170M Sagard Buyout Price Too Low
An IntegraMed America Inc. shareholder on Tuesday hit the company and its prospective buyer Sagard Capital Partners LP with a proposed class action seeking to block the pair's planned merger, which...To view the full article, register now.
Already a subscriber? Click here to view full article